HEADER MEMBRANE PROTEIN 25-OCT-19 6US9 TITLE INFLUENZA A M2 PROTON CHANNEL WILD TYPE TM DOMAIN BOUND TO R- TITLE 2 RIMANTADINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN 2; COMPND 3 CHAIN: A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS (A/JINFANG/132/2002(H3N2)); SOURCE 4 ORGANISM_TAXID: 751223 KEYWDS PROTON CHANNEL, RIMANTADINE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.L.THOMASTON,W.F.DEGRADO REVDAT 3 11-OCT-23 6US9 1 REMARK REVDAT 2 10-NOV-21 6US9 1 JRNL REVDAT 1 28-OCT-20 6US9 0 JRNL AUTH J.L.THOMASTON,M.L.SAMWAYS,A.KONSTANTINIDI,C.MA,Y.HU, JRNL AUTH 2 H.E.BRUCE MACDONALD,J.WANG,J.W.ESSEX,W.F.DEGRADO, JRNL AUTH 3 A.KOLOCOURIS JRNL TITL RIMANTADINE BINDS TO AND INHIBITS THE INFLUENZA A M2 PROTON JRNL TITL 2 CHANNEL WITHOUT ENANTIOMERIC SPECIFICITY. JRNL REF BIOCHEMISTRY 2021 JRNL REFN ISSN 0006-2960 JRNL PMID 34342217 JRNL DOI 10.1021/ACS.BIOCHEM.1C00437 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 21525 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.170 REMARK 3 FREE R VALUE TEST SET COUNT : 1758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.1806 - 4.7014 0.93 1570 125 0.2417 0.2919 REMARK 3 2 4.7014 - 3.7321 0.94 1515 137 0.2277 0.2538 REMARK 3 3 3.7321 - 3.2604 0.96 1535 144 0.2287 0.2456 REMARK 3 4 3.2604 - 2.9624 0.96 1564 139 0.2277 0.2634 REMARK 3 5 2.9624 - 2.7501 0.97 1538 133 0.2100 0.2595 REMARK 3 6 2.7501 - 2.5879 0.94 1512 145 0.2155 0.2343 REMARK 3 7 2.5879 - 2.4583 0.96 1515 127 0.2279 0.2342 REMARK 3 8 2.4583 - 2.3513 0.97 1549 149 0.2254 0.3268 REMARK 3 9 2.3513 - 2.2608 0.96 1530 129 0.2461 0.3200 REMARK 3 10 2.2608 - 2.1828 0.95 1513 133 0.2353 0.2825 REMARK 3 11 2.1828 - 2.1145 0.92 1421 136 0.2492 0.3209 REMARK 3 12 2.1145 - 2.0541 0.94 1526 130 0.2407 0.3267 REMARK 3 13 2.0541 - 2.0000 0.94 1479 131 0.2748 0.3985 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.600 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.055 3172 REMARK 3 ANGLE : 2.222 4400 REMARK 3 CHIRALITY : 1.373 628 REMARK 3 PLANARITY : 0.005 472 REMARK 3 DIHEDRAL : 14.997 1024 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6US9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1000245095. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1159 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21661 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 48.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6BKL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MONOOLEIN, 0.015 M TRICINE PH 8.5, 24% REMARK 280 W/V PEG 4000, 50 MM MNG-3-C8, R-RIMANTADINE, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.35050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: M, N, O, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ACE A 21 REMARK 465 SER A 22 REMARK 465 ACE B 21 REMARK 465 SER B 22 REMARK 465 ACE C 21 REMARK 465 SER C 22 REMARK 465 SER C 23 REMARK 465 ACE D 21 REMARK 465 SER D 22 REMARK 465 SER D 23 REMARK 465 ACE E 21 REMARK 465 SER E 22 REMARK 465 ACE F 21 REMARK 465 SER F 22 REMARK 465 SER F 23 REMARK 465 ACE G 21 REMARK 465 SER G 22 REMARK 465 ACE H 21 REMARK 465 SER H 22 REMARK 465 ACE I 21 REMARK 465 SER I 22 REMARK 465 ACE J 21 REMARK 465 SER J 22 REMARK 465 SER J 23 REMARK 465 ACE K 21 REMARK 465 SER K 22 REMARK 465 SER K 23 REMARK 465 ACE L 21 REMARK 465 SER L 22 REMARK 465 ACE M 21 REMARK 465 SER M 22 REMARK 465 SER M 23 REMARK 465 ACE N 21 REMARK 465 SER N 22 REMARK 465 ACE O 21 REMARK 465 SER O 22 REMARK 465 SER O 23 REMARK 465 ACE P 21 REMARK 465 SER P 22 REMARK 465 SER P 23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CA RIM F 102 O HOH F 203 1.20 REMARK 500 CA RIM A 101 O HOH A 201 1.98 REMARK 500 CA RIM I 101 O HOH I 202 2.02 REMARK 500 CA RIM F 102 O HOH F 201 2.02 REMARK 500 CA RIM N 101 O HOH N 204 2.07 REMARK 500 CA RIM N 101 O HOH N 201 2.17 REMARK 500 CA RIM A 101 O HOH A 203 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RIM A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL F 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RIM F 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RIM I 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL J 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue RIM N 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL P 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU B 46 and NH2 B REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU C 46 and NH2 C REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU D 46 and NH2 D REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU E 46 and NH2 E REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU F 46 and NH2 F REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU G 46 and NH2 G REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU H 46 and NH2 H REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU I 46 and NH2 I REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU J 46 and NH2 J REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU K 46 and NH2 K REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU L 46 and NH2 L REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU M 46 and NH2 M REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU N 46 and NH2 N REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU O 46 and NH2 O REMARK 800 47 REMARK 800 REMARK 800 SITE_IDENTIFIER: AE5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LEU P 46 and NH2 P REMARK 800 47 DBREF 6US9 A 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 B 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 C 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 D 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 E 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 F 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 G 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 H 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 I 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 J 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 K 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 L 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 M 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 N 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 O 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 DBREF 6US9 P 22 46 UNP D5F6K1 D5F6K1_9INFA 13 37 SEQADV 6US9 ACE A 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 A 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE B 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 B 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE C 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 C 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE D 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 D 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE E 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 E 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE F 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 F 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE G 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 G 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE H 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 H 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE I 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 I 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE J 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 J 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE K 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 K 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE L 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 L 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE M 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 M 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE N 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 N 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE O 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 O 47 UNP D5F6K1 AMIDATION SEQADV 6US9 ACE P 21 UNP D5F6K1 ACETYLATION SEQADV 6US9 NH2 P 47 UNP D5F6K1 AMIDATION SEQRES 1 A 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 A 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 A 27 NH2 SEQRES 1 B 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 B 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 B 27 NH2 SEQRES 1 C 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 C 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 C 27 NH2 SEQRES 1 D 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 D 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 D 27 NH2 SEQRES 1 E 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 E 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 E 27 NH2 SEQRES 1 F 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 F 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 F 27 NH2 SEQRES 1 G 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 G 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 G 27 NH2 SEQRES 1 H 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 H 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 H 27 NH2 SEQRES 1 I 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 I 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 I 27 NH2 SEQRES 1 J 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 J 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 J 27 NH2 SEQRES 1 K 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 K 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 K 27 NH2 SEQRES 1 L 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 L 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 L 27 NH2 SEQRES 1 M 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 M 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 M 27 NH2 SEQRES 1 N 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 N 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 N 27 NH2 SEQRES 1 O 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 O 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 O 27 NH2 SEQRES 1 P 27 ACE SER SER ASP PRO LEU VAL VAL ALA ALA SER ILE ILE SEQRES 2 P 27 GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP ARG LEU SEQRES 3 P 27 NH2 HET NH2 A 47 1 HET NH2 B 47 1 HET NH2 C 47 1 HET NH2 D 47 1 HET NH2 E 47 1 HET NH2 F 47 1 HET NH2 G 47 1 HET NH2 H 47 1 HET NH2 I 47 1 HET NH2 J 47 1 HET NH2 K 47 1 HET NH2 L 47 1 HET NH2 M 47 1 HET NH2 N 47 1 HET NH2 O 47 1 HET NH2 P 47 1 HET RIM A 101 39 HET CL C 101 1 HET CL F 101 1 HET RIM F 102 39 HET RIM I 101 39 HET CL J 101 1 HET RIM N 101 39 HET CL P 101 1 HETNAM NH2 AMINO GROUP HETNAM RIM RIMANTADINE HETNAM CL CHLORIDE ION HETSYN RIM 1-(1-ADAMANTYL)ETHANAMINE FORMUL 1 NH2 16(H2 N) FORMUL 17 RIM 4(C12 H21 N) FORMUL 18 CL 4(CL 1-) FORMUL 25 HOH *50(H2 O) HELIX 1 AA1 ASP A 24 LEU A 46 1 23 HELIX 2 AA2 ASP B 24 LEU B 46 1 23 HELIX 3 AA3 PRO C 25 LEU C 46 1 22 HELIX 4 AA4 PRO D 25 LEU D 46 1 22 HELIX 5 AA5 ASP E 24 LEU E 46 1 23 HELIX 6 AA6 PRO F 25 LEU F 46 1 22 HELIX 7 AA7 ASP G 24 LEU G 46 1 23 HELIX 8 AA8 ASP H 24 LEU H 46 1 23 HELIX 9 AA9 ASP I 24 LEU I 46 1 23 HELIX 10 AB1 PRO J 25 LEU J 46 1 22 HELIX 11 AB2 PRO K 25 ARG K 45 1 21 HELIX 12 AB3 ASP L 24 LEU L 46 1 23 HELIX 13 AB4 PRO M 25 ARG M 45 1 21 HELIX 14 AB5 ASP N 24 LEU N 46 1 23 HELIX 15 AB6 PRO O 25 LEU O 46 1 22 HELIX 16 AB7 PRO P 25 LEU P 46 1 22 LINK C LEU A 46 N NH2 A 47 1555 1555 1.33 LINK C LEU B 46 N NH2 B 47 1555 1555 1.33 LINK C LEU C 46 N NH2 C 47 1555 1555 1.33 LINK C LEU D 46 N NH2 D 47 1555 1555 1.33 LINK C LEU E 46 N NH2 E 47 1555 1555 1.33 LINK C LEU F 46 N NH2 F 47 1555 1555 1.33 LINK C LEU G 46 N NH2 G 47 1555 1555 1.33 LINK C LEU H 46 N NH2 H 47 1555 1555 1.33 LINK C LEU I 46 N NH2 I 47 1555 1555 1.33 LINK C LEU J 46 N NH2 J 47 1555 1555 1.33 LINK C LEU K 46 N NH2 K 47 1555 1555 1.33 LINK C LEU L 46 N NH2 L 47 1555 1555 1.33 LINK C LEU M 46 N NH2 M 47 1555 1555 1.33 LINK C LEU N 46 N NH2 N 47 1555 1555 1.33 LINK C LEU O 46 N NH2 O 47 1555 1555 1.33 LINK C LEU P 46 N NH2 P 47 1555 1555 1.33 SITE 1 AC1 11 ALA A 30 SER A 31 GLY A 34 HOH A 201 SITE 2 AC1 11 HOH A 202 HOH A 203 HOH A 206 HOH A 208 SITE 3 AC1 11 SER B 31 SER C 31 GLY D 34 SITE 1 AC2 3 TRP C 41 ARG C 45 TRP D 41 SITE 1 AC3 2 TRP E 41 TRP F 41 SITE 1 AC4 10 ALA F 30 SER F 31 GLY F 34 HOH F 201 SITE 2 AC4 10 HOH F 202 HOH F 203 HOH F 205 HOH F 206 SITE 3 AC4 10 SER G 31 GLY G 34 SITE 1 AC5 10 ALA I 30 SER I 31 HOH I 201 HOH I 202 SITE 2 AC5 10 HOH I 204 SER J 31 GLY J 34 GLY K 34 SITE 3 AC5 10 ALA L 30 HOH L 102 SITE 1 AC6 3 ARG J 45 TRP K 41 ARG K 45 SITE 1 AC7 13 ALA M 30 SER M 31 GLY M 34 HOH M 102 SITE 2 AC7 13 ALA N 30 SER N 31 GLY N 34 HOH N 201 SITE 3 AC7 13 HOH N 202 HOH N 204 ALA O 30 SER O 31 SITE 4 AC7 13 GLY O 34 SITE 1 AC8 2 TRP M 41 ARG P 45 SITE 1 AC9 4 ILE B 42 LEU B 43 ASP B 44 ARG B 45 SITE 1 AD1 4 ILE C 42 LEU C 43 ASP C 44 ARG C 45 SITE 1 AD2 4 ILE D 42 LEU D 43 ASP D 44 ARG D 45 SITE 1 AD3 4 ILE E 42 LEU E 43 ASP E 44 ARG E 45 SITE 1 AD4 5 ILE F 42 LEU F 43 ASP F 44 ARG F 45 SITE 2 AD4 5 PRO L 25 SITE 1 AD5 5 ILE G 42 LEU G 43 ASP G 44 ARG G 45 SITE 2 AD5 5 PRO I 25 SITE 1 AD6 5 ILE H 42 LEU H 43 ASP H 44 ARG H 45 SITE 2 AD6 5 SER N 23 SITE 1 AD7 4 ILE I 42 LEU I 43 ASP I 44 ARG I 45 SITE 1 AD8 5 SER B 23 ILE J 42 LEU J 43 ASP J 44 SITE 2 AD8 5 ARG J 45 SITE 1 AD9 5 PRO G 25 ILE K 42 LEU K 43 ASP K 44 SITE 2 AD9 5 ARG K 45 SITE 1 AE1 4 ILE L 42 LEU L 43 ASP L 44 ARG L 45 SITE 1 AE2 5 PRO A 25 ILE M 42 LEU M 43 ASP M 44 SITE 2 AE2 5 ARG M 45 SITE 1 AE3 5 PRO B 25 ILE N 42 LEU N 43 ASP N 44 SITE 2 AE3 5 ARG N 45 SITE 1 AE4 4 ILE O 42 LEU O 43 ASP O 44 ARG O 45 SITE 1 AE5 5 SER H 23 ILE P 42 LEU P 43 ASP P 44 SITE 2 AE5 5 ARG P 45 CRYST1 48.181 48.701 71.671 90.00 90.01 90.00 P 1 21 1 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020755 0.000000 0.000004 0.00000 SCALE2 0.000000 0.020533 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013953 0.00000